ALFA Filings
Every announcement, straight from the exchange
Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.
Announcement type
Time
122,865 announcements with these filters
M P K Steels (I) Ltd announced the results of its Extra-Ordinary General Meeting held on April 28, 2026. Shareholders approved a special resolution to shift the company's registered office from Assam to Rajasthan. The meeting concluded with all proposed business transacted successfully and requisite majority voting in favour.
Kkalpana Industries (India) Ltd confirmed it does not meet SEBI's 'Large Corporate' criteria for FY2026. The company reported zero outstanding long-term borrowings and no credit rating as of March 31, 2026, exempting it from specific incremental borrowing requirements.
ACI Infocom Ltd will hold an EGM on May 20, 2026, to appoint Mr. Sanjay Mandavia as Executive Director (remuneration: ₹0.11 Crore p.a.) and Mr. Navneet Kumar as Independent Director. Both appointments are for five-year terms commencing April 24, 2026.
Five-Star Business Finance Ltd disclosed a security cover of 1.20 times for its listed non-convertible debentures as of March 31, 2026. The company maintained sufficient asset cover ranging from 1.00 to 1.25 times. The statutory auditor, Deloitte Haskins & Sells, certified compliance with all financial covenants.
Avanse Financial Services Ltd reported revenue from operations of ₹2,892 Cr and net profit of ₹596.9 Cr for Q4 FY26.
Linde India Limited has submitted its initial disclosure confirming it does not meet the SEBI criteria for 'Large Corporate' classification as of March 31, 2026. The company reported zero outstanding long-term borrowings, exempting it from mandatory debt issuance requirements under the Large Corporate framework.
Vivid Global Industries Ltd submitted its annual disclosure under the SEBI Large Corporate framework for FY 2025-26. The company reported zero incremental borrowing and zero mandatory debt security issuance for the period. No penalties are applicable as there was no shortfall in borrowing requirements.
Assam Entrade Limited announced the resignation of M/s. Shivam Grover & Associates as Secretarial Auditor, effective April 28, 2026. The resignation is attributed to internal professional reasons, with no material concerns raised regarding management. The company's Audit Committee and Board will initiate the process to appoint a new Secretarial Auditor in due course.
Ameenji Rubber Limited (BSE: 544555) disclosed that it does not qualify as a 'Large Corporate' under SEBI's debt-raising framework for FY 2025-26. The company reported outstanding borrowings of ₹52.27 Crore as of March 31, 2026, and holds no credit rating for the previous financial year.
Mr. Boddu Sri Ram Chowdary has resigned as an Independent Director of MSR India Limited (BSE: 508922), effective April 28, 2026. The resignation is attributed to personal situations and commitments, with no other material reasons reported. This departure marks a change in the company's board composition.
Tata Motors Passenger Vehicles Limited has scheduled a Board Meeting for May 14, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 31, 2026, and a recommendation for a final dividend. The trading window for designated persons remains closed until May 16, 2026.
Life Insurance Corporation of India announced the cessation of Mr. Vinod Kumar Verma and Mr. Ranjan Sharma as Non-Executive Independent Directors. Both cessations are effective from April 28, 2026, due to the completion of their co-terminus terms of office. This transition reflects routine board tenure management.
Mitshi India Ltd has filed for non-applicability of SEBI Regulation 23(9) regarding Related Party Transaction reports for FY 2025-26. The company is exempt as its paid-up capital (₹8.80 Crore) and net worth (₹2.72 Crore) remain below the mandated thresholds of ₹10 Crore and ₹25 Crore, respectively.
Tata Motors Passenger Vehicles Ltd scheduled a Board meeting on May 14, 2026. The Board will consider audited financial results for FY26 and recommend a dividend. The company's trading window remains closed until 48 hours after the results announcement.
Bandhan Bank reports FY26 PAT of ₹1,223.56cr, down from ₹2,745.30cr YoY. Net Profit for Q4 FY26 stood at ₹534.14cr. Total Income for FY26 reached ₹24,423.14cr.
Five-Star Business Finance reported FY26 PAT of ₹10,988 Mn (+2% YoY) and AUM growth of 11% to ₹132,246 Mn. Strategy focuses on secured lending to small businesses via proprietary underwriting.
Somany Ceramics Limited has scheduled a Board Meeting for May 4, 2026, to consider audited financial results and a proposal for an interim dividend. The trading window for designated persons remains closed from April 1, 2026, until 48 hours after the results declaration.
Piramal Pharma Limited announced its FY26 results, reporting revenue of ₹8,869 Crore. Performance was impacted by inventory destocking and slower inflows, although the company maintained a strong quality track record with zero OAI. Management remains optimistic for FY27 growth driven by the CDMO and CHG businesses.
Manaksia Aluminium Company Ltd clarified that recent stock price movements are purely market-driven. The company confirmed it is in full compliance with SEBI listing regulations and has disclosed all material, price-sensitive information to the exchanges.
Emmvee Photovoltaic Power Ltd reported FY2026 revenue of ₹5,049.9 Crore, up 116% year-on-year, while PAT tripled to ₹1,081.6 Crore. The company expanded module capacity to 10.3 GW and plans further expansion to 16.3 GW by FY2028. Strong performance was driven by solar cell operations and manufacturing scale benefits.
OneSource Specialty Pharma Limited received an EU GMP Certificate for its Sterile Product Division in Bangalore from German authorities. The certification follows an October 2025 inspection and covers aseptic liquids, secondary packing, and quality control. This approval complements existing US-FDA, Health Canada, ANVISA, and TGA clearances, strengthening the facility's global sterile manufacturing capabilities.
Life Insurance Corporation of India (LIC) announced the cessation of Shri Vinod Kumar Verma and Dr. Ranjan Sharma as Independent Directors following the completion of their terms on April 28, 2026. Consequently, they also stepped down from their respective board committee positions.
Five-Star Business Finance reported its FY2026 results, achieving an 11% AUM growth to ₹13,225 Crore and a 2% PAT increase to ₹1,099 Crore. The company expanded its network to 844 branches, opening 9 new units during Q4. Despite asset quality headwinds, management noted improving collection efficiencies and expects 20% AUM growth for FY2027.
Rossari Biotech Limited's board has recommended a final dividend of 25% (Rs. 0.50 per equity share) for the financial year 2025-26. The record date and general meeting date for shareholder approval will be announced later.
Piramal Pharma Ltd reported revenue from operations of ₹2,752 Cr (-0.1% YoY) and a net loss of ₹8.8 Cr for Q4 FY26.
Piramal Pharma Limited reported its FY2026 audited financial results, showing standalone annual revenue of ₹4,782.01 Crore and PAT of ₹700.01 Crore. The Board also approved the re-appointment of Ms. Nandini Piramal as Chairperson and Mr. Peter DeYoung as Executive Director, alongside shifting the company's registered office and appointing a new Company Secretary.
Mitshi India Ltd reported revenue from operations of ₹1.3 Cr (+30.0% YoY) and net profit of ₹0 Cr for Q4 FY26.
Mitshi India Ltd approved its audited standalone financial results for the year ended March 31, 2026. The company reported annual income of ₹2.77 Crore and a net profit of ₹0.69 Lakhs. The auditor's report contains a qualified opinion regarding substantial cash transactions and pending confirmations for certain balances.
Rossari Biotech Limited announced that Ms. Aparna Sharma completed her tenure as Non-Executive Independent Director effective April 28, 2026. This is a routine board transition following the completion of an appointed term.
Equity shareholders of Torrent Pharmaceuticals Limited approved the Scheme of Amalgamation with J. B. Chemicals & Pharmaceuticals Limited. The resolution was passed with the requisite majority through remote e-voting and e-voting at the NCLT-convened meeting held on April 28, 2026.